Marta Garcia de Herreros

Medical Oncologist, Hospital Clinic Barcelona, Genitourinary tumors

[Carme @carmecrouss]

💥Poster session #ASCO26

📍Clinical impact & molecular profiling of PTENloss & TMPRSS2:ERG in mHSPC

➕correlation between PTENloss & TE+
❌ PTENloss/TE- had the worst clinical outcomes
✅ Among PTENloss, TE+ presented better outcomes>TE-
🧬 PTENloss/TE+ had enrichment of PI3K

[Begoña Mellado @begona_mellado]

Happy to share our last publication from a multicenter real-world study in Spain, exploring early non-cancer deaths in metastatic hormone-sensitive prostate cancer.#ICAMS,#C17,@hospitalclinic,@UniBarcelona,@idibaps
https://t.co/ug5xJhgJKP

[Marta Garcia de Herreros @MartaGdeH]

Great #ASCOGU meeting🌉 Proud to present 3 posters from our group:
- E.Lillo: AVPC prevalence in a mHSPC cohort
- C.Rodrigo: non-cancer deaths in mHSPC
- L. Fernández & @OscarReigMD: meta-analysis shows higher irAEs in adjuvant IO vs metastatic
@begona_mellado @hospitalclinic

[Òscar Reig @OscarReigMD]

📅 SAVE THE DATE!

El 5 de novembre de 2025, a l’Aula 4.1 de la Facultat de Medicina - Hospital Clínic, tindrà lloc la Jornada C17 d’Actualització en Tumors Urològics.

Una cita imprescindible per a professionals de l’oncologia! 🧬

#Oncologia #C17Uro2025

[Teresa Macarulla @MacarullaTeresa]

Representation of the Medical Oncology Department of @hospitalclinic. Proud of our team and our commitment to excellence in patient care, research, and education. #Oncology #HospitalClínic @idibaps @myESMO #ESMO25

[Begoña Mellado @begona_mellado]

¿Eres oncólogo médico interesado en cáncer urológico? Quizás te interesa trabajar y desarrollar tu carrera con nosotros en el @hospitalclinic . Escríbeme y comentamos los detalles

[Roberto Ferrara @RobertoFerrara_]

Environmental exposure does matter for NSCLC .
Provocative data on air pollution and radon effects on NSCLC screening and tumour microenvironment.
Pollution associated with higher adenok risk and radon correlated with more inflammed (TILs PDL1+) TME. @LauraMezquitaMD
#WCLC2025

[Marta Garcia de Herreros @MartaGdeH]

So happy to present the MIRROR study at #WCLC25 ✨ Exploring how radon☢️ & smoking 🚬 shape the inmune tumor microenvironment in NSCLC🫁
4-years journey⛵
Huge team effort across 16 hospitals!
Big thanks to our patients & everyone who made this possible🫂

[Begoña Mellado @begona_mellado]

Should medical oncologists prescribe #exercise in #prostate cancer pacientes on ADT? Find the evidence in our latest publication review.
https://t.co/PQswmVGTjJ

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

Exercise in patients with metastatic prostate cancer: A comprehensive review

https://t.co/UqFGDV1SRq

Physical activity🏃 and structured exercise have been shown to significantly improve quality of life in #ProstateCancer (PC) patients, particularly by alleviating side effects of androgen deprivation therapy (ADT) such as fatigue, bone loss, depression, and cognitive decline. Exercise also appears to enhance immune response and may help slow tumor progression through various cellular pathways. While most evidence comes from studies in non-metastatic PC populations, growing data support exercise as a valuable complementary strategy even in metastatic settings.

This review highlights the benefits of exercise in PC care and emphasizes the need for further research focused specifically on patients with advanced disease.

@MartaGdeH
@LaiaFManas
@OscarReigMD
@begona_mellado

@OncoAlert 🚨
@silkegillessen @AOmlin
@nataliagandur @bavilima @yekeduz_emre

[OncoDaily @oncodaily]

Marta Garcia de Herreros (@MartaGdeH) is the Winner of the IV Predoctoral Fellowship of the UB Chair of Innovation in Precision Oncology - Aleix Prat
@hospitalclinic @UniBarcelona

https://t.co/jiOkV0Gony

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews @CancerWorldmag

[Marta Garcia de Herreros @MartaGdeH]

@begona_mellado

[Marta Garcia de Herreros @MartaGdeH]

PTEN is emerging as a prognostic/predictive biomarker in #mHSPC (+CAPItello-281). But how to best assess PTEN loss?
Here we show that low PTEN mRNA links to poor outcomes in mHSPC and propose a new PTEN-loss prognostic gene signature https://t.co/MWruN1wXAL

[EORTC @EORTC]

#MCCRWorkshop Faculty & Fellows, class of 2025! Since 1999, this workshop has fostered innovation, collaboration, and groundbreaking research in clinical cancer.

#EORTC @myESMO @AACR

[Begoña Mellado @begona_mellado]

Demà t´esperem per celebrar el #Dia Mundial del #Cancer de #Pròstata. parlarem de diagnòstic precoç, recerca i de propostes per viure millor. És gratuït i obert a tothom!@hospitalclinic Clínic de Barcelona#Unitat d´Uro-Oncologia#ICAMS

[Marta Garcia de Herreros @MartaGdeH]

@to_carla96 @hospitalclinic Best team ever! Us esperem!!!

[clara @to_carla96]

Te interesa la Oncología Médica? Ven el día 20 de marzo a las puertas abiertas del ⁦@hospitalclinic⁩ a conocer nuestro servicio o contáctanos para cualquier duda! #MIR #MIR2025 ⁦⁩ #residentsCLÍNIC #CLÍNIC #medicina #residentes #oncología #oncologíamédica

[Marta Garcia de Herreros @MartaGdeH]

📢 Our superteam's participation in the ASCO-GU Congress #GU25
We had a great time in SF; science, friends, and collaboration! 🧬 👥 🌍
@OscarReigMD @begona_mellado @hospitalclinic

[Begoña Mellado @begona_mellado]

Working in understanding the molecular landscape of aggressive prostate cancer: alterations in PTEN,RB,P53 is associated to tumor chromosomal instability. @MartaGdeH presented our work at @ASCOGU

[European Urology Open Science @EurUrolOpen]

Brief Report: Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors by @MartaGdeH, Natalia Jiménez et al

Full article: https://t.co/UyhRy2YcMi

#UroSoMe #euros